Avenue Therapeutics (ATXI)
0.13
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form SC 13D/A AVENUE THERAPEUTICS, Filed by: Fortress Biotech, Inc.
April 17, 2024 4:06 PM - SEC Filing
Form 4 AVENUE THERAPEUTICS, For: Apr 16 Filed by: Fortress Biotech, Inc.
April 17, 2024 4:06 PM - SEC Filing
Form 8-K AVENUE THERAPEUTICS, For: Mar 26
March 29, 2024 2:42 PM - SEC Filing
Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024
March 25, 2024 8:30 AM - StreetInsider
Form DEF 14C AVENUE THERAPEUTICS, For: Mar 18
March 18, 2024 4:59 PM - SEC Filing
Form 10-K AVENUE THERAPEUTICS, For: Dec 31
March 18, 2024 4:16 PM - SEC Filing
Form 8-K AVENUE THERAPEUTICS, For: Mar 18
March 18, 2024 4:11 PM - SEC Filing
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
March 18, 2024 4:05 PM - Globe NewsWire
Avenue Therapeutics (ATXI) Receives Positive Nasdaq Listing Determination
March 15, 2024 8:16 AM - StreetInsider
Avenue Therapeutics Receives Positive Listing Determination from Nasdaq
March 15, 2024 8:15 AM - StreetInsider
Form 8-K AVENUE THERAPEUTICS, For: Mar 11
March 15, 2024 7:16 AM - SEC Filing
Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting
March 11, 2024 8:01 AM - StreetInsider
Avenue Therapeutics (ATXI) to Execute 1:30 to 1:75 Reverse Share Split
March 8, 2024 4:46 PM - StreetInsider
Form PRE 14C AVENUE THERAPEUTICS, For: Mar 08
March 8, 2024 4:32 PM - SEC Filing
Form 8-K AVENUE THERAPEUTICS, For: Mar 06
March 8, 2024 4:16 PM - SEC Filing
Form 8-K AVENUE THERAPEUTICS, For: Feb 20
February 23, 2024 4:22 PM - SEC Filing
Avenue Therapeutics (ATXI) Reports Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101
February 22, 2024 8:32 AM - StreetInsider
Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy
February 22, 2024 8:30 AM - Globe NewsWire
Form EFFECT AVENUE THERAPEUTICS,
February 2, 2024 6:04 AM - SEC Filing
Form 424B3 AVENUE THERAPEUTICS,
February 2, 2024 6:02 AM - SEC Filing
Form DEF 14C AVENUE THERAPEUTICS, For: Jan 29
January 29, 2024 8:01 AM - SEC Filing
Avenue Therapeutics (ATXI) Announces 33.08M Share Offering by Selling Stockholders
January 24, 2024 4:15 PM - StreetInsider
Form S-3 AVENUE THERAPEUTICS,
January 24, 2024 4:12 PM - SEC Filing
Full Article List
